Efficacy of a glucagon-like peptide-1 agonist and restrictive versus liberal oxygen supply in patients undergoing coronary artery bypass grafting or aortic valve replacement: study protocol for a 2-by-2 factorial designed, randomised clinical trial.
Sebastian WibergJesper KjaergaardRasmus MøgelvangChristian Holdflod MøllerKristian KandlerHanne Berg RavnChristian HassagerLars KøberJens Christian NilssonPublished in: BMJ open (2021)
NCT02673931.
Keyphrases
- coronary artery bypass grafting
- aortic valve replacement
- clinical trial
- patients undergoing
- aortic stenosis
- coronary artery disease
- transcatheter aortic valve implantation
- aortic valve
- percutaneous coronary intervention
- open label
- double blind
- phase ii
- study protocol
- transcatheter aortic valve replacement
- phase iii
- ejection fraction
- placebo controlled
- acute coronary syndrome
- randomized controlled trial
- left ventricular
- heart failure
- atrial fibrillation